Exxon Mobil, Trinity Biotech, and NuScale Power are the three Hydrogen stocks to watch today, according to MarketBeat's stock screener tool. Hydrogen stocks are shares of publicly traded companies involved in the production, distribution and storage of hydrogen as an energy carrier, as well as the development of fuel cells and related infrastructure. Investors buy these equities to gain exposure to the emerging hydrogen economy, which aims to decarbonize industries and complement renewable power through clean-burning hydrogen technologies. These companies had the highest dollar trading volume of any Hydrogen stocks within the last several days.
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
XOM stock traded down $0.81 during trading hours on Thursday, reaching $106.79. The stock had a trading volume of 5,212,293 shares, compared to its average volume of 16,721,637. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.25 and a quick ratio of 0.88. The stock has a 50-day simple moving average of $110.09 and a 200 day simple moving average of $108.91. The stock has a market capitalization of $455.26 billion, a PE ratio of 15.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.53. Exxon Mobil has a fifty-two week low of $97.80 and a fifty-two week high of $126.34.
Read Our Latest Research Report on XOM
Trinity Biotech (TRIB)
Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Shares of TRIB stock traded up $0.89 on Thursday, reaching $1.90. The stock had a trading volume of 173,772,743 shares, compared to its average volume of 2,390,530. The firm's 50-day moving average is $0.72 and its two-hundred day moving average is $0.72. The firm has a market capitalization of $34.30 million, a price-to-earnings ratio of -0.64 and a beta of 0.77. Trinity Biotech has a 12 month low of $0.48 and a 12 month high of $3.44.
Read Our Latest Research Report on TRIB
NuScale Power (SMR)
NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.
Shares of SMR stock traded down $1.82 on Thursday, reaching $35.48. The stock had a trading volume of 6,862,096 shares, compared to its average volume of 11,600,331. The firm has a market capitalization of $10.09 billion, a price-to-earnings ratio of -29.87 and a beta of 2.06. The firm's 50-day moving average is $41.18 and its two-hundred day moving average is $27.20. NuScale Power has a 12 month low of $6.88 and a 12 month high of $53.50.
Read Our Latest Research Report on SMR
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exxon Mobil, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exxon Mobil wasn't on the list.
While Exxon Mobil currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.